Epilepsia Open publishes results of post hoc data analysis of FINTEPLA® (fenfluramine) in patients with Lennox-Gastaut syndrome
FINTEPLA is approved by the U.S. Food and Drug Administration (FDA) for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) and Dravet syndrome (DS) in patients two years … [+19952 chars]
Source / Credit
This story is credited to PRNewswire. Some news APIs provide excerpts only. Full licensed republication depends on your API/content rights.